As the experiment data shown in Figure 4(a), linc00511 overexpression could reduce the drug sensitivity of pancreatic cancer to DET in vivo. The detailed grouping and intervention strategies are listed in Figure 4(b). Here, LINC00511 is linked to pancreatic neoplasm.